RBOT icon

Vicarious Surgical

12.00 USD
-0.03
0.25%
At close Dec 20, 4:00 PM EST
After hours
12.23
+0.23
1.92%
1 day
-0.25%
5 days
-14.95%
1 month
32.89%
3 months
108.33%
6 months
69.25%
Year to date
-0.50%
1 year
-6.32%
5 years
-96.83%
10 years
-96.83%
 

About: Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

Employees: 131

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 2 (+1) [Q3]

0.83% less ownership

Funds ownership: 35.93% [Q2] → 35.11% (-0.83%) [Q3]

5% less capital invested

Capital invested by funds: $11M [Q2] → $10.4M (-$585K) [Q3]

13% less funds holding

Funds holding: 38 [Q2] → 33 (-5) [Q3]

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

42% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 12

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$10.50
13%
downside
Avg. target
$10.50
13%
downside
High target
$10.50
13%
downside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Piper Sandler
Adam Maeder
63% 1-year accuracy
10 / 16 met price target
13%downside
$10.50
Neutral
Maintained
13 Nov 2024

Financial journalist opinion

Neutral
Business Wire
2 weeks ago
Vicarious Surgical Announces Departure of Chief Financial Officer
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the pending departure of William Kelly, its Chief Financial Officer (CFO), to pursue other career opportunities, after nearly four years of dedicated service with the Company. Mr. Kelly has served as Vicarious Surgical's CFO since January 2021. He will assist.
Vicarious Surgical Announces Departure of Chief Financial Officer
Neutral
Seeking Alpha
1 month ago
Vicarious Surgical Inc. (RBOT) Q3 2024 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco – Director-Investor Relations Adam Sachs – Co-Founder and Chief Executive Officer Bill Kelly – Chief Financial Officer Conference Call Participants Adam Maeder – Piper Sandler Operator Hello, everyone, and welcome to Vicarious Surgical's Third Quarter 2024 Earnings Call. My name is Lydia and I'll be your operator today.
Vicarious Surgical Inc. (RBOT) Q3 2024 Earnings Call Transcript
Neutral
Business Wire
1 month ago
Vicarious Surgical Reports Third Quarter 2024 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the quarter ended September 30, 2024. Management will host a corresponding conference call at 4:30 p.m. ET today, November 12, 2024. “Our team's strong execution throughout the year, continuing in the third quarter, has us on track to ac.
Vicarious Surgical Reports Third Quarter 2024 Financial Results
Neutral
Business Wire
1 month ago
Vicarious Surgical to Report Third Quarter 2024 Financial Results on November 12, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the third quarter ended September 30, 2024 after the market closes on Tuesday, November 12, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in li.
Vicarious Surgical to Report Third Quarter 2024 Financial Results on November 12, 2024
Neutral
Business Wire
4 months ago
Vicarious Surgical to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the Company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York. Management is scheduled to present in a fireside chat on Friday, September 6, 2024 at 11:30 a.m. ET. About Vicarious Surgical Founded in 2014, Vicarious S.
Vicarious Surgical to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Neutral
Seeking Alpha
4 months ago
Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Transcript
Vicarious Surgical Inc (NYSE:RBOT ) Q2 2024 Results Conference Call August 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Bill Kelly - CFO & Treasurer Adam Sachs - Co-Founder, CEO & Director Conference Call Participants Eric Anderson - TD Cowen Andrew Ranieri - Morgan Stanley Ryan Zimmerman - BTIG Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2024 Second Quarter Earnings Call.
Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Transcript
Neutral
Business Wire
4 months ago
Vicarious Surgical Reports Second Quarter 2024 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the quarter ended June 30, 2024. Management will host a corresponding conference call at 4:30 p.m. ET today, August 12, 2024. “Our team's effective execution of our development plans during the first half of this year has positioned us w.
Vicarious Surgical Reports Second Quarter 2024 Financial Results
Positive
Zacks Investment Research
4 months ago
Vicarious Surgical (RBOT) Partners LSU Health New Orleans
Vicarious Surgical (RBOT) teams up with LSU Health New Orleans to advance its V1.0 surgical robot. It aims to file for FDA approval by 2026.
Vicarious Surgical (RBOT) Partners LSU Health New Orleans
Neutral
Business Wire
4 months ago
Vicarious Surgical Announces New Hospital System Partnership with LSU Health New Orleans
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that it has signed a strategic development agreement with the LSU Health New Orleans. LSU Health New Orleans is Louisiana's flagship and most comprehensive academic health sciences center. Known for the quality of its academic and training programs, the cente.
Vicarious Surgical Announces New Hospital System Partnership with LSU Health New Orleans
Neutral
Business Wire
4 months ago
Vicarious Surgical to Report Second Quarter 2024 Financial Results on August 12, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through the transformation of surgical robotics, today announced it will report financial results for the second quarter ended June 30, 2024 after the market closes on Monday, August 12, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interes.
Vicarious Surgical to Report Second Quarter 2024 Financial Results on August 12, 2024
Charts implemented using Lightweight Charts™